Triton-backed Triley Bidco has announced it will acquire UK-based pharmaceutical company Clinigen Group for 925 pence per share, valuing the company at GBP 1.3bn.
Triton acquires Clinigen at increased GBP 1.3bn valuation
Most Popular
Triton-backed Triley Bidco has announced it will acquire UK-based pharmaceutical company Clinigen Group for 925 pence per share, valuing the company at GBP 1.3bn.